BlossomHill Therapeutics Inc.

BLSM | NASDAQ

Price Alert Chart Builder DCF Calculator

$26.80

+$1.06 (+4.12%)

At close: Sep 21, 2026, 4:00 PM ET

$26.14

-$0.66 (-2.46%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $748.55M

Enterprise Value $686.39M

Beta 0.00

Average Volume 271.99K

Shares Outstanding (Diluted) 29.08M

Shares Change YoY N/A

Institutional Ownership N/A

Exchange NASDAQ

ISIN US0951301003

Price Performance

Price Change 1M 63.6%

Price Change 3M 67.5%

Price Change 6M 67.5%

Price Change YTD 67.5%

Price Change 1Y 67.5%

Price Change 3Y 67.5%

Price Change 5Y 67.5%

1M CAGR (ann.) 60.9%

1Y CAGR (ann.) N/A

5Y CAGR (ann.) N/A

All-Time CAGR 5559.2%

Valuation

PE Ratio -37.22

Forward PE N/A

PEG Ratio -0.24

Forward PEG 1.80

PS Ratio N/A

Forward PS N/A

PB Ratio -5.12

P/FCF Ratio -37.20

P/Adj. FCF Ratio -36.63

P/OCF Ratio -24.36

EV/Sales N/A

EV/EBIT -31.05

EV/EBITDA -31.23

EV/FCF -32.76

Earnings Yield -2.7%

FCF Yield -2.7%

Adj. FCF Yield -2.7%

Financial Health

Net Cash $116M

Total Debt $23.02M

Cash & Short-Term Investments $116M

Total Assets $143.41M

Current Ratio 7.40

Quick Ratio 7.40

Debt / Equity Ratio -0.15

Debt / EBITDA -1.05

Debt / FCF -1.10

OCF / Debt -0.91

Interest Coverage 0.00

Altman Z-Score 0.35

Piotroski F-Score 0

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -1.5%

Returns

Return on Assets -22.0%

Return on Equity 20.7%

Return on Invested Capital -26.3%

Return on Capital Employed -26.4%

Return on Tangible Assets -22.0%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Sep 17, 2026

EPS Estimate (next Q) -$0.93

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $33.67

Price Target Upside 25.6%

Cash Flow

Operating Cash Flow $-20.94M

Free Cash Flow $-20.95M

Adj. Free Cash Flow $-21.28M

FCF Per Share -$1.11

OCF Per Share -$1.10

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-22.11M

EBITDA $-21.98M

Net Income $-21.01M

EPS (Diluted) -$0.72

Revenue / Employee N/A

Profit / Employee $-333.46K

Employees 63